fingolimod hydrochloride has been researched along with Vascular Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Girard, M; Labrie, M; Muccilli, A; Nehme, A; Odier, C; Poppe, AY | 1 |
| Hirt, SW; Lehle, K; Puehler, T; Schmid, C; von Suesskind-Schwendi, M | 1 |
| Xie, M; Zhou, JH | 1 |
| Brooks, SF; Chun, J; Fontaine, BA; Luster, AD; Shea, BS; Tager, AM | 1 |
| Hosch, W; Korporal, M; Max, R; Schwarz, A; Wildemann, B | 1 |
5 other study(ies) available for fingolimod hydrochloride and Vascular Diseases
| Article | Year |
|---|---|
Varicella-zoster virus vasculopathy in a multiple sclerosis patient on fingolimod.
Topics: Adult; Constriction, Pathologic; Female; Fingolimod Hydrochloride; Herpesvirus 3, Human; Humans; Lymphopenia; Multiple Sclerosis, Relapsing-Remitting; Risk Factors; Vascular Diseases | 2019 |
Early administration of FTY720 prevents chronic airway as well as vascular destruction in experimental rat lung transplantation.
Topics: Acute Disease; Animals; Bronchiolitis Obliterans; Chronic Disease; Drug Administration Schedule; Fingolimod Hydrochloride; Graft Rejection; Immunosuppressive Agents; Lung; Lung Transplantation; Lymphocytes; Male; Propylene Glycols; Rats; Rats, Inbred F344; Rats, Inbred WKY; Sclerosis; Sphingosine; Time Factors; Vascular Diseases | 2013 |
[FTY720 reduces peritubular micrangium loss in renal interstitial fibrotic rats].
Topics: Animals; Apoptosis; Capillaries; Fibrosis; Fingolimod Hydrochloride; Kidney Diseases; Kidney Tubules; Male; Propylene Glycols; Rats; Rats, Sprague-Dawley; Sphingosine; Vascular Diseases | 2009 |
Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury.
Topics: Animals; beta-Alanine; Bleomycin; Blood Coagulation; Endothelial Cells; Fibrosis; Fingolimod Hydrochloride; Humans; Lung Injury; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Oxadiazoles; Pneumonia; Propylene Glycols; Pulmonary Alveoli; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Survival Analysis; Thiophenes; Vascular Diseases | 2010 |
Critical vasospasm during fingolimod (FTY720) treatment in a patient with multiple sclerosis.
Topics: Adult; Arm; Blood Flow Velocity; Female; Fingolimod Hydrochloride; Humans; Multiple Sclerosis, Relapsing-Remitting; Propylene Glycols; Sphingosine; Vascular Diseases | 2010 |